This inventor holds 1 USPTO granted patent and 2 EPO patents. Top assignee: Orphelia Pharma. Active years: 2020.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2020
Title: Marie-Pierre Flament: Innovator in Solid Dosage Forms
Introduction
Marie-Pierre Flament is a notable inventor based in Phalempin, France. She has made significant contributions to the field of pharmaceuticals, particularly in the development of solid dosage forms.
Latest Patents
Marie-Pierre Flament holds a patent for a solid dosage form comprising vigabatrin. This invention includes a superdisintegrant, which can be chosen from crospovidone, a cellulose derivative, or a starch derivative. Additionally, it incorporates a non-reducing sugar, such as mannitol, xylitol, or sorbitol, along with a stearate derivative, specifically sodium stearyl fumarate or magnesium stearate.
Career Highlights
Throughout her career, Marie-Pierre has worked with prominent organizations, including Orphelia Pharma and Université de Lille. Her work has focused on enhancing the efficacy and delivery of pharmaceutical compounds.
Collaborations
Marie-Pierre has collaborated with notable colleagues, including Charles Uzarama and Patrick Gosselin. Their combined expertise has contributed to advancements in pharmaceutical formulations.
Conclusion
Marie-Pierre Flament's innovative work in solid dosage forms exemplifies her commitment to improving pharmaceutical delivery systems. Her contributions continue to impact the field positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile